The conversation discusses hair regrowth, with the user using finasteride (1 mg), topical minoxidil, and microneedling. A reply suggests the user's hair appears fuller and healthier.
The user is using finasteride, minoxidil, topical minoxidil with tretinoin, a derma stamp, and ketoconazole shampoo for hair regrowth. They experienced shedding after increasing the dose but are hopeful for fuller hair by November or December.
PP405 is a promising new treatment for hair loss that activates dormant stem cells in hair follicles, potentially bypassing the effects of DHT. It is currently in phase 2 trials and could be available between 2027 and 2030, but it is not considered a definitive cure.
The conversation is about someone observing potential hair regrowth after using finasteride/dutasteride, minoxidil, and RU58841 for almost three months. Multiple replies agree that the individual is experiencing hair regrowth.
User tries dermapen for hair loss and plans to use non-mainstream topicals like c60, ghk-cu, and ptd-dbm with valproic acid. They also use a head massager and modified LLLT belt for additional treatment.
The user experienced hair regrowth and darker hair using finasteride daily, minoxidil nightly, and occasional dermarolling. They noticed significant progress, especially in hair density, and are considering increasing minoxidil use despite itchiness from wearing a hat.
The user is using a hair loss treatment regimen including Avodart (dutasteride), oral minoxidil, LLLT caps, vitamins, and ketoconazole shampoo, and is considering adding dermarolling and RU58841. They are experiencing unwanted body hair growth from minoxidil and are planning for a future hair transplant.
The user "natiggiz" shared their early progress in filling in bald patches using topical finasteride, minoxidil, RU58841, ketoconazole, and derma stamp. Other users commented on the great results and expressed jealousy.
The user is using finasteride and minoxidil for hair loss but is looking for new treatments. Pyrilutamide and GT20029 are potential future treatments, with Pyrilutamide expected next year and GT20029 possibly by 2027.
The user recently started topical dutasteride and microneedling, and has been using RU58841 and Minoxidil for 16 months. They are curious if small black dots at their hairline indicate hair regrowth.
The conversation discusses hair regrowth progress using finasteride 0.5 mg daily, minoxidil 5% twice a day, and dermarolling 0.75 mm weekly. The user also takes vitamin D3K2, magnesium, and zinc supplements.
A 30-year-old male switched from finasteride to a combination of dutasteride, oral minoxidil, and RU58841, achieving significant hair growth without side effects. He plans to add GHK-Cu peptide to his regimen for further improvement.
Microneedling is effective for hair growth, especially when combined with finasteride and minoxidil, but concerns exist about potential long-term skin damage. Users report increased collagen and elastin deposition, but the long-term effects on the scalp remain uncertain.
The user experienced significant hair regrowth with topical finasteride, minoxidil, ketoconazole, and dermarolling, but later faced severe hair shedding after stopping dermarolling and reducing ketoconazole use. Suggestions included switching to oral treatments, resuming dermarolling, and considering lifestyle changes.
The conversation discusses hair regrowth strategies, including using dutasteride, minoxidil, finasteride, dermastamping, soy, curcumin, and possibly castor oil. Suggestions also include increasing dutasteride dosage, using oral minoxidil, topical finasteride, and tretinoin to enhance minoxidil efficacy.
The user experienced significant eyebrow and eyelash growth after starting a hair loss treatment routine that includes oral minoxidil, oral dutasteride, topical minoxidil, Nizoral shampoo, microneedling, and supplements. They also reported positive scalp hair gains and no significant side effects.
The user shared progress pictures of hair regrowth using 1mg finasteride, 5% topical minoxidil, derma stamping, and rosemary and mint hair oil. Responses varied, with some noting visible regrowth and others questioning the effectiveness of the oils.
The conversation is about the potential of the RCH-01/Replicel hair loss treatment and its lack of updates since 2013, with the user expressing hope for its success and considering using Minoxidil, finasteride, and dermarolling in the meantime. Other treatments mentioned as promising are Breezula and Tsuji.
User started balding at 16 and began treatment at 18, using RU58841, minoxidil, derma rolling, and peptides. After 6 months, they experienced significant hair regrowth and are happy with the results.
Pelage executives' hairlines were discussed, with speculation about them using PP405 for hair regrowth. Concerns were raised about using untested drugs, with some suggesting executives might not risk using them without safety data.
User visited derma doctor, suggested finasteride, minoxidil, multivitamins, and PRP therapy. Another user advised against PRP due to cost and ineffectiveness.
The user reports noticeable hair growth after 5 weeks using finasteride, minoxidil, dermarolling, and ketoconazole. They seek confirmation of their progress and question if they are a hyper responder.
The conversation discusses the need for a localized 5-alpha reductase inhibitor that only affects the scalp without systemic side effects, similar to pyrilutamide's approach. Current treatments like topical liposomal finasteride and dutasteride are mentioned, but concerns about their systemic effects and lack of research are highlighted.
Hair loss affects confidence, with discussions on treatments like finasteride, minoxidil, and RU58841. Emphasis is placed on self-acceptance and building confidence beyond appearance.
A 15-year-old experiencing severe diffuse thinning plans to use minoxidil, dermarolling, and possibly ketoconazole, with hopes to later incorporate finasteride. Concerns about starting finasteride too young and the need for a dermatologist consultation are discussed.
A 28-year-old man regrew hair using 1mg finasteride, 2.5mg oral minoxidil, a multivitamin, and a derma roller over 1 year and 9 months. Initial side effects resolved, and he maintains his hair with continued treatment.
PTD-DBM therapy for hair loss is being developed by Dr. Kang-Yell Choi, with human testing planned in South Korea. Some clinics in the U.S. offer PTD-DBM/valproic acid therapy, but it hasn't completed trials yet.